4J12 | monomeric Fc | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Ishino, T., Wang, M., Mosyak, L., Tam, A., Duan, W., Svenson, K., Joyce, A., Hara, D.O., Lin, L., Somers, W., Kriz, R. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 | ||||||||||||
ligand | BMA, MAN, NAG | enzyme |
| ||||||||||||
Primary reference | Engineering a Monomeric Fc Domain Modality by N-Glycosylation for the Half-life Extension of Biotherapeutics., Ishino T, Wang M, Mosyak L, Tam A, Duan W, Svenson K, Joyce A, O'Hara DM, Lin L, Somers WS, Kriz R, J Biol Chem. 2013 Jun 7;288(23):16529-37. doi: 10.1074/jbc.M113.457689. Epub 2013, Apr 24. PMID:23615911 |
Data retrieval |
View 4J12 in 3D |
Visual 3D analysis of 4J12 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4J12 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |